Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2. - Stewart-Jones GBE; Elbashir SM; Wu K; Lee D; Renzi I; Ying B; Koch M; Sein CE; Choi A; Whitener B; Garcia-Dominguez D; Henry C; et al. (Science translational medicine, 2023)